Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLH-2109 in Endometriosis
NCT02778919Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- May 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of linzagolix in endometriosis (6 arms), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Numerical Rating Scale score of pelvic pain at 12 weeks. Started May 2016; status: completed.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02778919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778919.